Closed
(KGOG1026)
Comparative anaylsis of CA-IX, p16, proliferative markers and human papilloma virus (HPV) in the diagnosisi of significant cervical lesions in patients with a cytologic diagnosis of atypical glandular cells(AGC)
Closed
(KGOG1023)
Phase III randomized study of concurrent chemotherapy and pelvic radiation therapy with or without adjuvant chemotherapy in high-risk patients with early-stage cervical carcinoma following radical hysterectomy
Closed
(KGOG1022)
GOG-233: Utility of preoperative FDG-PET/CT scanning prior to primary chemoradiation therapy to detect retroperitoneal lymph node metastasis in patients with locoregionally advanced carcinoma of the cervix (IB2, IIA ≥4 CM, IIB-IVA) or endometrium (Grade 3 endometrioid endometrial carcinoma; serous papillary carcinoma, clear cell carcinoma, or carcinosarcoma (any grade); and Grade 1 or 2 endometriord endometrial carcinoma with cervical stromal involvement overt in clinical examination or confirmed by endocervical curettage)
Closed
(KGOG3038)
MOCCA : A Multicentre Phase II randomised trial of Durvalumab (MEDI4736) versus physician’s choice chemotherapy in recurrent ovarian clear cell adenocarcinomas
Finished
(KGOG4004)
Finished
(KGOG3052)
Retrospective-Progression free survival in women who received Bevacizumab vs. Olaparib Maintenance after 2nd line chemotherapy for BRCAm platinum sensitive recurrent ovarian cancer (BOM)
Finished
(KGOG3048R)
Gonadotropin-releasing hormone (GnRH) agonist for prevention of chemotherapy induced menopause in malignant ovarian germ cell tumor: a multicenter study
Finished
(KGOG3048)
Gonadotropin-releasing hormone (GnRH) agonist for prevention of chemotherapy induced menopause in malignant ovarian germ cell tumor: a multicenter prospective study
Finished
(KGOG3047)
Nation-wide analysis of clinical NGS panel to perform precision oncology for epithelial ovarian, peritoneal and tubal cancer patient
Finished
(KGOG3046)
TRU-D: A phase II study of neoadjuvant chemotherapy plus Durvalumab (MEDI4736) and Tremelimumab in Advanced-stage ovarian cancer
* (사)대한부인종양연구회는 게시된 세부 임상연구 정보에 대해 법적 책임이 없습니다.